Vape 店内的含醉大麻产品：美国，2023 年。

Intoxicating Cannabis Products in Vape Shops: United States, 2023.

机构信息

Department of Health Administration and Health Policy, School of Public Health, The University of North Texas Health Science Center, Fort Worth, Texas.

Department of Prevention and Community Health, Milken Institute School of Public Health, George Washington University, Washington, District of Columbia.

出版信息

Am J Prev Med. 2024 Nov;67(5):776-784. doi: 10.1016/j.amepre.2024.07.001. Epub 2024 Jul 11.

DOI:10.1016/j.amepre.2024.07.001

PMID:39002889

Abstract

INTRODUCTION

Since 2020, many types of intoxicating cannabis products have entered the U.S. market. Hemp-derived intoxicating cannabis products, including hexahydrocannabinol and delta-8 tetrahydrocannabinol, pose concerns regarding their youth-oriented marketing, potency, and health effects. Some states have attempted to ban, restrict, or regulate their sale. However, the effectiveness of these laws and their enforcement is unclear. This study provides insights into the retail landscape of intoxicating cannabis products sold across the U.S.

METHODS

In November-December 2023, researchers systematically identified, called, and completed brief surveys with 520 U.S. vape shops: (n=10 per state, n=10 in District of Columbia, n=10 in Puerto Rico). The survey assessed the availability of 6 commonly sold intoxicating cannabis products. Data were analyzed by regulatory context. Analyses were conducted in 2024.

RESULTS

A total of 74% of vape shops sold any intoxicating cannabis products. Intoxicating cannabis products were sold in 43% of shops in states with delta-8 tetrahydrocannabinol bans, 53% in states with substantial regulations (intended to support safe use), 90% in states with significant restrictions (intended to limit potency/availability), and 92% in states with limited/no regulations. Intoxicating cannabis products were sold in vape shops in each state except Washington and Alaska, both of which banned hemp-derived intoxicating cannabis products and had active retail of legalized nonmedical cannabis.

CONCLUSIONS

Taking licensed dispensaries into consideration, intoxicating cannabis products can be purchased in retail stores located in all 50 states; Washington, District of Columbia; and Puerto Rico. Intoxicating cannabis products are widely available in vape shops, even in most states with relevant bans/restrictions. Enhanced laws, surveillance, and enforcement are needed. The 2024 Farm Bill and state laws should explicitly prohibit hemp-derived intoxicating cannabis products.

摘要

简介

自 2020 年以来，许多类型的致醉大麻产品进入美国市场。包括六氢大麻酚和 delta-8 四氢大麻酚在内的源自大麻的致醉大麻产品，因其面向年轻人的营销、效力和健康影响而令人担忧。一些州试图禁止、限制或监管其销售。然而，这些法律的有效性及其执行情况尚不清楚。本研究提供了美国各地销售的致醉大麻产品零售情况的相关见解。

方法

在 2023 年 11 月至 12 月期间，研究人员系统地识别、致电并完成了对美国 520 家蒸气烟商店的简短调查：（每个州 10 个，哥伦比亚特区 10 个，波多黎各 10 个）。该调查评估了 6 种常见销售的致醉大麻产品的供应情况。数据按监管背景进行分析。分析于 2024 年进行。

结果

共有 74%的蒸气烟商店销售任何致醉大麻产品。在有 delta-8 四氢大麻酚禁令的州，有 43%的蒸气烟商店销售致醉大麻产品，在有大量法规（旨在支持安全使用）的州，有 53%的蒸气烟商店销售致醉大麻产品，在有严格限制（旨在限制效力/可用性）的州，有 90%的蒸气烟商店销售致醉大麻产品，在法规有限/没有的州，有 92%的蒸气烟商店销售致醉大麻产品。除了华盛顿和阿拉斯加这两个州，这两个州都禁止源自大麻的致醉大麻产品，并对合法的非医用大麻进行了零售，在每个州都可以在蒸气烟商店购买致醉大麻产品。